Press Releases
🇪🇺 EMA Page 6EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 61–72 of 121 articles
Center for Cancer and Blood Disorders Launches CAR T-Cell Therapy Program in Maryland, Expanding Community Access
SamaCare Launches Industry-First Prior Authorization Performance Benchmarks for Medical Benefit Drugs
Repertoire Immune Medicines Doses First Patient in RPTR-1-201 Phase 1/2 Trial for Advanced Solid Tumors
Alpha Tau Treats First Patient with Alpha DaRT in European Pancreatic Cancer Trial ACAPELLA
Alpha Tau Treats First European Pancreatic Cancer Patient with Alpha DaRT in ACAPELLA Clinical Trial
Healthcare Third-Party Logistics Market to Double by 2034, Reaching $502.6 Billion Driven by Pharmaceutical Growth
Pharmaceutical Intermediates Market to Reach $57 Billion by 2035 as Generic Drug Manufacturing Drives 4.5% Annual Growth
Abivax Presents Obefazimod Phase 3 Data at Digestive Disease Week 2026
Pet Service Holding Reports 2025 Annual Results Amid European Veterinary Regulatory Changes
Femasys Launches FemaSeed Complete Fertility Solution for OB/GYNs at ACOG 2026
Mauna Kea Technologies Secures CE Mark Under New MDR, Expands European Medical Device Approvals
Pembrolizumab Plus Lenvatinib Shows Promise for Rare Clear Cell Gynecological Cancers in Phase 2 Trial